Indoco Remedies Ltd Share Price

Q: What is the share price of Indoco Remedies Ltd today?

Indoco Remedies Ltd share price as on 12 Jun 2026 is ₹246.6

Pharmaceuticals

NSE: INDOCO Small Cap ISIN: INE873D01024

As on 13 June 2026 at 02:33 IST

₹246.60

+ 3.60

(1.48%)

Sell Buy

Over 1 Month

11%

Over 6 Months

1.48%

Over 1 Year

-13.43%

Over 3 Years

-26.58%

Indoco Remedies Ltd Summary

Close ₹243

Open ₹207

High ₹245.95

Low ₹205

Volume 1,09,72,328

Net Turnover (in Cr) ₹257.04

52Wk High ₹349.80

52Wk Low ₹162.19

52Wk High / Low

162.19

349.80

Indoco Remedies Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹2,242.98

EPS (TTM) -

Book Value (BV) 119.08

Div. Yield 0.08 %

P/E (TTM) -400.08

Price/Book Value 2.05

Delivery % 9.26 %

Face Value 2

Key Ratios

PE Ratio -

PB Ratio 1.95

EV to Sales 1.91

PEG Ratio -

ROA -0.46

ROE -0.89

Debt-Equity 0.57

Net Profit Margin -0.65

Operating Profit Margin 9.64

Indoco Remedies Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,670.37	1,827.13	1,670.95	1,543.08	1,244.64
Total Expenses	1,745.74	1,702.86	1,478.15	1,306.51	1,112.65
Profit Before Tax	-74.37	135.80	192.79	236.57	132
Profit After Tax	-77.95	97	142.25	154.80	93.05
Operating Profit After Depreciation	-9.14	162.29	217.82	250.71	154.26

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	1,041.30	976.23	736.46	623.82	613.01
Total Non Current Assets	1,428.58	1,190.06	844.63	712.47	692.54
Total Current Assets	1,001.34	954.67	813.57	773.62	622.53
Total Assets	2,429.91	2,144.73	1,658.20	1,486.09	1,315.06
Total Shareholder's Fund	1,022	1,109.90	1,028.25	904.64	768.99

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	94.93	155.39	178.83	173.83	82.22
Net Cash Used In Investing Activities	-339.11	-431.89	-208.17	-121.41	-66.69
Net Cash Used In Financing Activities	241.42	280.43	22.80	-44.37	-29.87

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,536.67	1,799.32	1,669.02	1,542.04	1,243.42
Total Expenses	1,545.04	1,657.62	1,477.43	1,305.81	1,112.06
Profit Before Tax	-7.38	153.23	191.59	236.23	131.35
Profit After Tax	-8.73	116.64	141.36	154.52	92.39
Operating Profit After Depreciation	48.26	178.51	216.62	250.37	153.57

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	798.80	754.28	719.66	623.70	612.89
Total Non Current Assets	1,245.69	1,060.39	847.21	714.79	694.62
Total Current Assets	955.47	900.21	812.47	772.78	621.95
Total Assets	2,201.16	1,960.61	1,659.67	1,487.57	1,316.57
Total Shareholder's Fund	1,103.36	1,126.62	1,027.02	904.30	768.93

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	90.77	176.78	178.79	173.55	82.17
Net Cash Used In Investing Activities	-259.79	-301.70	-208.51	-121.41	-66.70
Net Cash Used In Financing Activities	168.62	122.40	22.81	-44.37	-29.83

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	475.61	445.36	484.67	439.67	390.21
Total Expenses	425.90	413.85	441.62	422.14	390.99
Profit Before Tax	-25	-31.31	-13.53	-36.66	-45.52
Profit After Tax	-23.68	-29.45	-9.21	-36.35	-41.34
Operating Profit after Depreciation	49.67	32.49	43.81	19.16	1.24

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	449.13	400.51	442.12	392.53	347.25
Total Expenses	386.10	374.61	388.73	377.70	343.79
Profit Before Tax	27.62	-20.45	9.76	-28.40	-30.90
Profit After Tax	27.35	-20	15.05	-28.06	-26.24
Operating Profit after Depreciation	73.38	33.07	59.93	20.41	9.96

Indoco Remedies Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 216.68

S2 190.37

S3 175.73

Pivot 231.32

R1 257.63

R2 272.27

R3 298.58

Moving Average

20 SMA 209.77

50 SMA 209.15

100 SMA 206.76

200 SMA 237.02

Indoco Remedies Ltd Corporate Actions

Indoco Remedies Ltd

₹0.2/Share

Announcement Date 04 Sep 2025

Record Date 04 Sep 2025

Div Yield 10%

AGM Date: 23 Sep 2021

AGM 23/09/2021 Summary of proceedings of the 74th Annual General Meeting of the Company held on 23rd September 2021(As Per BSE Announcement Dated on 9/23/2021 10:31:46 AM) Details of voting results in Compliance with Regulation 44 of the LODR in relation to 74th Annual General Meeting [AGM] of the Company held on 23rd September 2021(As Per BSE Announcement Dated on 9/24/2021 7:19:15 AM)

AGM Date: 22 Sep 2022

AGM 22/09/2022 Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Thursday 15th September, 2022 as the Record Date for determining entitlement of members to final dividend for the financial year ended 31st March, 2022. The Register of members and Share Transfer books of the Company will remain closed from Friday, 16th September, 2022 to Thursday, 22nd September, 2022 (both days inclusive) for taking record of the Members of the Company for the purpose of payment of Dividend and AGM. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 09th September, 2015, we are attaching herewith the Notice of the 75th Annual General Meeting of the Company. (As Per BSE Announcement Dated on 22.08.2022) Proceedings of 75th Annual General Meeting of Indoco Remedies Limited (As Per BSE Announcement Dated on 22.09.2022) 1) Re-appointment of M/s Gokhale & Sathe, a Firm of Chartered Accountants, (Firm Registration No. 103264W) as Statutory Auditors of the Company for the second term of 5 consecutive years. 2.) Re-appointment of Ms. Aditi Panandikar (DIN: 00179113) as Managing Director 3). Re-appointment of Mr. Sundeep V Bambolkar (DIN: 00176613) as Jt. Managing Director Link of the Webcast of 75th AGM of Indoco Remedies Limited held on 22.09.2022 Disclosure of Voting Results of the 75th Annual General Meeting of the Company held on Thursday, 22nd September, 2022 as required under Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Scrutinizers Report (As per BSE Announcement Dated on 23/9/2022)

AGM Date: 26 Sep 2023

NEWSPAPER ADVERTISEMENT - 76TH ANNUAL GENERAL MEETING TO BE HELD ON 26TH SEPTEMBER, 2023 THROUGH VIDEO CONFERENCING (VC)/OTHER AUDIO-VISUAL MEANS (OAVM) Pursuant to Regulation 42 of SEBI(LODR) Regulations, 2015, the Company has fixed Tuesday, 19th September, 2023 as the Record Date. PURSUANT TO REGULATION 30 AND 34 OF THE SEBI (LODR) REGULATIONS,2015, ENCLOSED HEREWITH NOTICE OF THE 76TH AGM AND THE ANNUAL REPORT FOR THE FINANCIAL YEAR 2022-2023 . PURSUANT TO REGULATION 34 OF SEBI (LODR)REGULATIONS 2015, ENCLOSED HEREWITH THE ANNUAL REPORT FOR THE FINANCIAL YEAR 2022-2023 THE REGISTER OF MEMBERS AND SHARE TRANSFER BOOKS OF THE COMPANY WILL REMAIN CLOSE FROM 20-09-2023 TO 26-09-2023 (BOTH DAYS INCLUSIVE) FOR THE PURPOSE OF PAYMENT OF FINAL DIVIDEND AND AGM. (As Per BSE Announcement Dated on 01/09/2023) Voting Results of 76th AGM of Indoco Remedies Limited along with the Scrutinizers Report (As Per BSE Announcement Dated on 26/09/2023)

AGM Date: 26 Sep 2024

AGM 26/09/2024 Pursuant to Regulation 42 of the Securities and Exchange Board of India (LODR) Regulations,2015, the Company has fixed Thursday,19th September, 2024 as the Record Date. (As Per BSE Announcement Dated on 30.08.2024) Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are submitting herewith the details regarding the proceedings of the 77th AGM of the Company held on Thursday, 26th September, 2024 through Video Conferencing/Other Video Visual Means (As Per BSE Announcement dated on 26.09.2024) Please find enclosed the details of Voting Results and Scrutinizers Report for the 77th AGM of the Company held on 26th September, 2024 (As per BSE Announcement dated on 27/09/2024)

AGM Date: 11 Sep 2025

AGM 11/09/2025 Intimation of Cut -off date for E-Voting, Book Closure and Record Date for Dividend Please find enclosed the details of Voting Results & Scrutinizers Report for the 78th AGM of the Company held on 11th September, 2025 (As Per Bse Announcement dated on 12/09/2025)

Indoco Remedies Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Indoco Remedies Ltd Top Mutal Funds Invested

Fund Name	AUM
DSP Healthcare Fund	2.06%
ICICI Pru P.H.D Fund	0.47%
Tata India Innovation Fund	0.46%
Nippon India Pharma Fund	0.45%
HDFC Value Fund	0.44%

Indoco Remedies Ltd News

Indoco Remedies climbs after Baddi plant secures EU GMP certification; ICICI Prudential MF buys 1.47% stake

Indoco Remedies rose 4.04% to Rs 211.60 after the company said its oral solid dosage formulations facility at Baddi, Himachal Pradesh, received European Union Good Manufacturing Practice (EU GMP) certification from the German Health Authority (Berlin

29 May 2026, 12:25 pm

Indoco Remedies receives EU GMP certification from Malta Medicines Authority

14 May 2026, 11:20 am

Indoco Remedies gains after reporting turnaround Q4 performance

Indoco Remedies surged 12.90% to Rs 257.35 after the company reported a standalone net profit of Rs 27.35 crore in Q4 FY26 compared with a net loss of Rs 26.24 crore in Q4 FY25.

07 May 2026, 03:29 pm

Board of Indoco Remedies recommends Final Dividend

Of Rs.0.20 per share

07 May 2026, 12:47 pm

Indoco Remedies to announce Quarterly Result & final dividend

On 7 May 2026

28 Apr 2026, 12:06 pm

Indoco Remedies Ltd Stock Analysis

Annual revenue for Indoco Remedies Ltd decreased by 14.60% to ₹1,536.67 crore in FY 2025 from ₹1,799.32 crore in FY 2024.
Annual Net Profit for Indoco Remedies Ltd decreased by 107.49% to ₹-8.73 crore in FY 2025 from ₹116.64 crore in FY 2024.
Promoter Shareholding in Indoco Remedies Ltd decreased by 0.06% in the most recent quarter, from 58.90% in December 2025 to 58.86% in March 2026.
Indoco Remedies Ltd delivered a 1-year return of -13.43% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Indoco Remedies Ltd share price moved up by 1.48% from its previous close of INR ₹243. The latest Indoco Remedies Ltd share price is INR ₹246.60.
Indoco Remedies Ltd share price today has been at a low of 243 and a high of 261.71. Over the past 52 weeks, the Indoco Remedies Ltd share price has seen a low of 162.19 and a high of 349.80.